The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $124.88

Today's change-0.17 -0.14%
Updated March 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $124.88

Today's change-0.17 -0.14%
Updated March 29 4:00 PM EDT. Delayed by at least 15 minutes.

Abiomed Inc down (U.S.)$0.17

Abiomed Inc closed lower Wednesday, dropping (U.S.)$0.17 or 0.14% to (U.S.)$124.88. Over the last five days, shares have gained 1.14% and 10.83% year to date. Shares have outperformed the S&P 500 by 19.22% during the last year.

Key company metrics

  • Open(U.S.) $124.79
  • Previous close(U.S.) $125.05
  • High(U.S.) $125.85
  • Low(U.S.) $124.21
  • Bid / Ask-- / --
  • YTD % change+10.83%
  • Volume278,875
  • Average volume (10-day)254,329
  • Average volume (1-month)309,654
  • Average volume (3-month)407,392
  • 52-week range(U.S.) $89.74 to (U.S.) $132.95
  • Beta0.49
  • Trailing P/E116.38×
  • P/E 1 year forward106.53×
  • Forward PEG4.18×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.07
Updated March 29 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.63%

Based on its net profit margin of 11.63%, Abiomed Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.38%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue11510310394
Total other revenue--------
Total revenue11510310394
Gross profit96868879
Total cost of revenue19171515
Total operating expense89888274
Selling / general / administrative54535145
Research & development16181614
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income25152120
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax26152120
Income after tax1591311
Income tax, total10699
Net income1591311
Total adjustments to net income--------
Net income before extra. items1591311
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1591311
Inc. avail. to common incl. extra. items1591311
Diluted net income1591311
Dilution adjustment----0--
Diluted weighted average shares45454545
Diluted EPS excluding extraordinary itemsvalue per share0.340.200.290.24
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.340.200.290.24